F

FUTRUE Neurosciences

Develops brain-computer interfaces and neuromodulation devices

Venture Manager Brain-Computer Interfaces

Program ManagementUpdated on Nov 7
Full-timeGräfelfing, GermanyNo salary listedHybrid

About the Job

Requirements

  • Proven track record of leading complex development projects in a hardware-related field and excellent technical understanding.
  • At least 2–3 years of relevant work experience in a top-tier consulting firm or a similarly dynamic environment.
  • A degree in Electrical Engineering, Computer Science, Mechatronics, Mechanical Engineering, Biomedical Engineering, Medical Technology, Neuroscience, or a comparable field.
  • Business-fluent English at a minimum C1 level.
  • Ability to quickly familiarize yourself with new subject areas and communicate complex issues concisely.

Responsibilities

  • Analyze and assess the latest state of science and technology and the commercial potential of BCI application scenarios, then translate findings into strategic recommendations for management.
  • Set up and manage a development plan to build the venture's innovative lead.
  • Build a team of engineers to support BCI design and development, including electrodes and chips.
  • Establish and lead Quality, Regulatory, and Clinical Trial functions; develop Market Access and sales structures; and ensure successful market launch of the BCI.
  • Coordinate interfaces with development partners and internal FUTRUE teams, and manage the development timeline and budget.

About the Company

FUTRUE Neurosciences

Develops brain-computer interfaces and neuromodulation devices

FUTRUE Neurosciences develops brain-computer interfaces and neuromodulation devices to help people with paralysis or neurological injuries regain movement, speech, and touch. Its core technology is high-resolution neurointerfaces, including a mikro-ECoG microelectrode array with 512 brain-surface electrodes for targeted stimulation and recording. The system decodes neural signals to control prosthetic movement, translates neural activity into speech, and provides targeted nerve stimulation to restore sensation, aiming for initial clinical applications. The company differentiates itself through German-engineered, high-precision neurointerfaces built by lean, independent teams within the FUTRUE Group, backed by substantial resources and founder Clemens Fischer’s track record, with the goal of bringing the next generation of BCIs to clinical use by 2030.

Company size
Not listed
Company stage
Not listed
Total funding
Not listed
Headquarters
Gräfelfing, Germany
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at FUTRUE Neurosciences

See more jobs